 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
: a, t; e+ y. s3 [( P1 d
! i$ w5 |9 N" ^( i( ]% p" DEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.6 g0 W7 r3 X4 z/ L" o9 Z4 A
) w1 G4 Q6 x3 a1 Y3 Y
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007, i. b, S( H) t: Y2 L+ r
+ |' _$ E* p' C# H
$ |( Z1 l) \1 o( O% D
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
9 g4 x" L. z# C
) K7 S+ ]" G3 e2 U3 \+ aThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
i# |7 t/ f! K) t, J; ?+ R: A; V9 M! F9 b
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.0 Q2 X# L$ i- n
7 {& C+ E' v( W1 M
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
8 ^5 i/ I7 U0 x# |; h1 M8 H4 `: O# m1 D& y7 Y
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
# t) c- K- e+ T) m$ F7 u5 n
: x7 Q- \7 @+ p"As a scientist, it's one of the highlights of my CAREER," Shan said.
) Y6 b1 F& ]+ Y( J
3 @3 g# b# ? _$ ~; w4 v+ u; B"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
2 g, _) h& O- D& H- i& O. k9 u3 l" F. I% v2 W" G; P* c+ N
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
: I4 O% c4 z }( z/ Z/ `# u1 v* `& }' i) w6 v4 N0 M
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
* G1 \" z5 d6 \5 ?; P7 s' P
& y# I7 t7 t+ R/ w& g9 P {( TThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.. R' Q A3 c0 u1 K/ g8 r4 T
2 o9 A# l3 |( D) j! R
2 I' B+ M5 ^, f. \ G whttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|